Torbjörn Egelrud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Torbjörn Egelrud has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- A R Companjen
Department of Immunology, Erasmus University Rotterdam (EUR), PO Box 1738, 3000 DR Rotterdam, The Netherlands
1 shared publication E N Lundqvist
Department of Dermatology, Umeå University, Sweden
1 shared publicationElisabet Nylander Lundqvist
Department of Dermatology, Umeå University, Sweden
1 shared publication- Errol P. Prens
Department of Dermatology, Erasmus University Medical Center, Rotterdam, Netherlands
1 shared publication Maria Brattsand
Department of Public Health, Umeâ University, SE-901 85 Umeâ, Sweden
1 shared publication
Latest Publications
- Open Access
- 10 May 2000
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 80, 44-45
Desquamation in the Stratum Corneum
To maintain a constant thickness of the stratum corneum the desquamation rate and the de novo produc...
- 10 May 2000
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 80, 44-45
Open AccessDesquamation in the Stratum Corneum
To maintain a constant thickness of the stratum corneum the desquamation rate and the de novo produc...
- Open Access
- 1 October 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (42) , 30033-30040
Purification, Molecular Cloning, and Expression of a Human Stratum Corneum Trypsin-like Serine Protease with Possible Function in Desquamation
- 1 October 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (42) , 30033-30040
Open AccessPurification, Molecular Cloning, and Expression of a Human Stratum Corneum Trypsin-like Serine Protease with Possible Function in Desquamation
- 1 March 1998
- Vol. 9 (1) , 41-6
Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
We have recently presented evidence that human plantar stratum corneum and psoriatic scales contain biologically active interleukin-1beta (IL-1beta) which has been activated in a process not involving interleukin-1beta-converting-enzyme. The aim of the present study was to compare this form of native IL-1beta with recombinant mature human IL-1beta as regards activity and the effects of inhibitors. In an assay based on the ability of IL-1 to induce the expression of E-selectin in cultured endothelial cells, the maximal activity of IL-1beta partially purified from plantar stratum corneum and recombinant IL-1beta was approximately the same. The specific activity was slightly higher for recombinant IL-1beta, although this difference was within one order of magnitude. An antibody to IL-1beta caused total inhibition of both forms of IL-1beta with no significant differences in the dose-response curves for the antibody. Immunochemical analyses and experiments with neutralising antibodies specific for IL-1alpha and tumor necrosis factor-alpha (TNF-alpha) verified that the observed activity in the partially purified preparation was due to IL-1beta, and not to IL-1alpha or TNF-alpha. There were no significant differences between the two forms of IL-1beta as regards the inhibitory effects of recombinant IL-1 receptor antagonist. Partially purified IL-1beta from plantar stratum corneum and from psoriatic scales were both highly active in the D10 proliferation assay. This activity could be totally inhibited with an IL-1beta specific antibody. This work thus confirms the presence of biologically active IL-1beta in plantar stratum corneum and psoriatic scales. Alternatively activated IL-1beta in the epidermis should be considered in future studies on skin biology and pathophysiology.
- 1 March 1998
- Vol. 9 (1) , 41-6
Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
We have recently presented evidence that human plantar stratum corneum and psoriatic scales contain biologically active interleukin-1beta (IL-1beta) which has been activated in a process not involving interleukin-1beta-converting-enzyme. The aim of the present study was to compare this form of native IL-1beta with recombinant mature human IL-1beta as regards activity and the effects of inhibitors. In an assay based on the ability of IL-1 to induce the expression of E-selectin in cultured endothelial cells, the maximal activity of IL-1beta partially purified from plantar stratum corneum and recombinant IL-1beta was approximately the same. The specific activity was slightly higher for recombinant IL-1beta, although this difference was within one order of magnitude. An antibody to IL-1beta caused total inhibition of both forms of IL-1beta with no significant differences in the dose-response curves for the antibody. Immunochemical analyses and experiments with neutralising antibodies specific for IL-1alpha and tumor necrosis factor-alpha (TNF-alpha) verified that the observed activity in the partially purified preparation was due to IL-1beta, and not to IL-1alpha or TNF-alpha. There were no significant differences between the two forms of IL-1beta as regards the inhibitory effects of recombinant IL-1 receptor antagonist. Partially purified IL-1beta from plantar stratum corneum and from psoriatic scales were both highly active in the D10 proliferation assay. This activity could be totally inhibited with an IL-1beta specific antibody. This work thus confirms the presence of biologically active IL-1beta in plantar stratum corneum and psoriatic scales. Alternatively activated IL-1beta in the epidermis should be considered in future studies on skin biology and pathophysiology.
- 1 September 1997
- Published by Wiley in European Journal of Immunology
- Vol. 27 (9) , 2165-2171
Biologically active, alternatively processed interleukin‐1β in psoriatic scales
The aims of the present work were to elucidate the biochemical properties of interleukin‐1β (IL‐1β) in psoriatic scales to get information on the processing of epidermal IL‐1β in psoriasis, and to elucidate whether the IL‐1β in psoriatic scales possesses biological activity. By means of ion exchange chromatography, IL‐1β in extracts of psoriatic scales was purified to a stage where it could be analyzed with electrophoretic methods and immunoblotting. Compared to mature recombinant human IL‐1β (Ala 117 IL‐1β), IL‐1β in psoriatic scales had a slightly higher apparent molecular mass and a more acidic isoelectric point, as revealed by two‐dimensional electrophoresis under denaturing conditions. Isoelectric focusing under non‐denaturing conditions of IL‐1β partially purified from psoriatic scales, or from non‐inflamed plantar stratum corneum (Nylander Lundqvist, E., Bäck, O. and Egelrud, T., J. Immunol. 1996. 157: 1699), and of mature IL‐1β, followed by immunoblotting with IL‐1β‐specific antibodies, showed that psoriatic scales contained two components with IL‐1β‐like immuno‐reactivity which were isoelectric at pH 6.1 and 6.3, respectively. Theses components could also be detected in extracts of plantar stratum corneum, which also contained small amounts of an IL‐1β‐like component isoelectric at pH 6.9. Mature IL‐1β was isoelectric at pH 6.9. No IL‐1β‐like biological activity could be detected in crude extracts of psoriatic scales. These extracts also contained high amounts of IL‐1 receptor antagonist. Partially purified preparations of IL‐1β from psoriatic scales, in which an apparently total separation of IL‐1β and IL‐1 receptor antagonist had been achieved, could induce expression of E‐selectin in human umbilical vein endothelial cells. This activity was inhibited by antibodies specific for IL‐1β, but not by antibodies specific for IL‐1α. It is concluded that psoriatic scales contain biologically active IL‐1β, which has been processed by a mechanism which may be similar to that present in non‐inflamed plantar stratum corneum, and which does not involve IL‐1β converting enzyme.
- 1 September 1997
- Published by Wiley in European Journal of Immunology
- Vol. 27 (9) , 2165-2171
Biologically active, alternatively processed interleukin‐1β in psoriatic scales
The aims of the present work were to elucidate the biochemical properties of interleukin‐1β (IL‐1β) in psoriatic scales to get information on the processing of epidermal IL‐1β in psoriasis, and to elucidate whether the IL‐1β in psoriatic scales possesses biological activity. By means of ion exchange chromatography, IL‐1β in extracts of psoriatic scales was purified to a stage where it could be analyzed with electrophoretic methods and immunoblotting. Compared to mature recombinant human IL‐1β (Ala 117 IL‐1β), IL‐1β in psoriatic scales had a slightly higher apparent molecular mass and a more acidic isoelectric point, as revealed by two‐dimensional electrophoresis under denaturing conditions. Isoelectric focusing under non‐denaturing conditions of IL‐1β partially purified from psoriatic scales, or from non‐inflamed plantar stratum corneum (Nylander Lundqvist, E., Bäck, O. and Egelrud, T., J. Immunol. 1996. 157: 1699), and of mature IL‐1β, followed by immunoblotting with IL‐1β‐specific antibodies, showed that psoriatic scales contained two components with IL‐1β‐like immuno‐reactivity which were isoelectric at pH 6.1 and 6.3, respectively. Theses components could also be detected in extracts of plantar stratum corneum, which also contained small amounts of an IL‐1β‐like component isoelectric at pH 6.9. Mature IL‐1β was isoelectric at pH 6.9. No IL‐1β‐like biological activity could be detected in crude extracts of psoriatic scales. These extracts also contained high amounts of IL‐1 receptor antagonist. Partially purified preparations of IL‐1β from psoriatic scales, in which an apparently total separation of IL‐1β and IL‐1 receptor antagonist had been achieved, could induce expression of E‐selectin in human umbilical vein endothelial cells. This activity was inhibited by antibodies specific for IL‐1β, but not by antibodies specific for IL‐1α. It is concluded that psoriatic scales contain biologically active IL‐1β, which has been processed by a mechanism which may be similar to that present in non‐inflamed plantar stratum corneum, and which does not involve IL‐1β converting enzyme.